Beschlussvorlage (BHKW 15.7)

7. Page 1 of 5 MSDS Ref. No: QS-MSD-135 Version: US/Canada Date Approved: 15 Jan., 2014 Revision No: 10 Material Safety Data Sheet 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME: CHEMICAL FAMILY: MOLECULAR FORMULA: ALTERNATE TRADE NAME(S): GENERAL USE: Lithium Bromide Solution, Blend Inhibited Lithium Salts LiBr ADVAGuard® 750 Lithium Bromide Solution Industrial Manufacturing MANUFACTURER FMC CORPORATION Lithium Division P.O. Box 795 Bessemer City, NC 28016-0795 General Information: (704) 868-5300 Emergency Telephone Numbers: CHEMTREC (800) 424-9300 Emergency Phone (704) 629-5361 (Plant) Call Collect 24 Hr/Day Emergency Phone (303) 595-9048 (Medical) Call Collect 2. COMPOSITION / INFORMATION ON INGREDIENTS Chemical Name Lithium bromide Water CAS # 7550-35-8 7732-18-5 Wt.% 52 - 56 44 - 48 3. HAZARDS IDENTIFICATION EMERGENCY OVERVIEW IMMEDIATE CONCERNS: POTENTIAL HEALTH EFFECTS: Clear, colorless, odorless solution. This product is severely irritating to the eyes and skin, and expected to be irritating to the mucous membranes. COMMENTS: (See Section 11, Toxicological Information) 4. FIRST AID MEASURES EYES: SKIN: INGESTION: INHALATION: Immediately flush with water for at least 15 minutes, lifting the upper and lower eyelids intermittently. See a medical doctor or ophthalmologist immediately. Immediately flush with plenty of water while removing contaminated clothing and/or shoes, and thoroughly wash with soap and water. Obtain immediate medical attention. Contact a medical doctor if necessary. Rinse mouth with water. Dilute by giving 1 or 2 glasses of water. Do not induce vomiting. Never give anything by mouth to an unconscious person. See a medical doctor immediately. Remove to fresh air. If breathing discomfort occurs and persists, see a medical doctor. If breathing has stopped, give artificial respiration and see a medical doctor immediately. Page 2 of 5 MSDS Ref. No: QS-MSD-135 Version: US/Canada Date Approved: 15 Jan., 2014 Revision No: 10 NOTES TO MEDICAL DOCTOR: This product is practically non-toxic by ingestion, inhalation, or dermal exposure. It is severely irritating to the skin, and expected to be severely irritating to the eyes and mucous membranes. Dermal exposure may cause sensitization. Consideration should be given to gastric lavage, with endotracheal tube in place. Treatment is controlled removal of exposure with symptomatic and supportive care. 5. FIRE FIGHTING MEASURES FLAMMABLE LIMITS: GENERAL HAZARD: EXTINGUISHING MEDIA: HAZARDOUS COMBUSTION PRODUCTS: FIRE FIGHTING PROCEDURES: AUTOIGNITION TEMPERATURE: PROPERTIES CONTRIBUTING TO FLAMMABILITY: FLASH POINT: SENSITIVITY TO STATIC DISCHARGE: SENSITIVITY TO IMPACT: Upper: Not available Lower: Not available. No known physical hazard, non-combustible. Dry chemical, CO2, water spray or regular foam. None Wear full protective clothing and self-contained breathing apparatus (SCBA) approved for fire fighting. This is necessary to protect against the hazards of heat, products of combustion and oxygen deficiency. Do not breathe smoke, gases or vapors generated. Not applicable None Not applicable Not applicable Not applicable COMMENTS: (See Section 10, Stability and Reactivity) 6. ACCIDENTAL RELEASE MEASURES RELEASE NOTES: Contain spill with absorbent. Transfer or pump into a suitable container. Dispose of waste according to local and Federal laws and regulations. Before cleanup measures begin, review the entire MSDS with particular attention to Section 3, Emergency Overview and Potential Health Effects; and Section 8, Recommended Personal Protective Equipment. 7. HANDLING AND STORAGE HANDLING: Avoid contact with eyes, skin or clothing. Avoid breathing mist. Use with adequate ventilation. Wear safety glasses or goggles and rubber gloves. Wash thoroughly after handling. Keep away from strong acids. Keep container closed. STORAGE: 8. EXPOSURE CONTROLS / PERSONAL PROTECTION EXPOSURE LIMITS Chemical Name TWA (ACGIH) STEL/Ceiling (ACGIH) PEL (OSHA) None ENGINEERING CONTROLS: Use local exhaust ventilation to keep airborne concentrations below exposure limits. PERSONAL PROTECTIVE EQUIPMENT STEL/Ceiling (OSHA) Page 3 of 5 MSDS Ref. No: QS-MSD-135 Version: US/Canada Date Approved: 15 Jan., 2014 Revision No: 10 Eyes And Face: Respiratory: Protective Clothing: Work Hygienic Practices: Safety glasses or goggles If product is misting or when engineering controls are not adequate, wear a NIOSH/MSHA respirator approved for inorganic dusts and mists. Rubber gloves Quick-drench eyewash and safety shower. 9. PHYSICAL AND CHEMICAL PROPERTIES ODOR: APPEARANCE: pH: PERCENT VOLATILE: VAPOR PRESSURE: VAPOR DENSITY: BOILING POINT: MELTING POINT: SOLUBILITY IN WATER: EVAPORATION RATE(Butyl Acetate = 1): SPECIFIC GRAVITY: MOLECULAR WEIGHT: COEFF. OIL/WATER: ODOR THRESHOLD: FLAMMABLE LIMITS: FLASH POINT: AUTOIGNITION TEMPERATURE: EXPLOSIVE PROPERTIES: OXIDIZING PROPERTIES: Odorless Clear, colorless liquid 7-9 Not applicable Not applicable Not applicable 140°C (284°F) Not applicable Miscible in any proportion Not applicable 1.6 g/cc at 25°C 86.84 Not available Not applicable Upper: Not available Lower: Not available. Not applicable Not applicable Not explosive Not an oxidizer 10. STABILITY AND REACTIVITY CONDITIONS TO AVOID: STABILITY: POLYMERIZATION: HAZARDOUS DECOMPOSITION PRODUCTS: INCOMPATIBLE MATERIALS: Contact with strong acids Stable Will not occur None None 11. TOXICOLOGICAL INFORMATION Eye Contact: Skin Contact: Skin Absorption: Ingestion: Inhalation: Severely irritating (rabbit) (52 - 54% LiBr aqueous solution) Severely irritating (rabbit) (52 - 54% LiBr aqueous solution) Dermal LD50: > 2000 mg/kg (rat) (52 - 54% LiBr aqueous solution) Oral LD50: > 2000 mg/kg (rat) (52 - 54% LiBr aqueous solution) [FMC Study I962080] [FMC Study I962082] [FMC Study I962079] [FMC Study I962081] Inhalation LC50: > 15.57 mg/L/4 hr. (rat) (52 - 54% LiBr aqueous solution) [FMC Study I962087] Page 4 of 5 MSDS Ref. No: QS-MSD-135 Version: US/Canada Date Approved: 15 Jan., 2014 Revision No: 10 Acute Effects From Overexposure: This product is practically non-toxic by ingestion, inhalation, or dermal exposure. It is severely irritating to the eyes and skin, and expected to be irritating to the mucous membranes. Causes skin sensitization in lab animals, and may produce similar effects in humans. Large doses of lithium bromide may cause central nervous system depression. Chronic Effects From Overexposure: No data available for the product. Chronic absorption of lithium bromide may cause central nervous system disturbances (drowsiness, lack of coordination, ataxia, depression, psychoses) and skin rashes. Sensitization: Carcinogenicity: Sensitizing (guinea pig) [FMC Study I96-2083] (52 - 54% LiBr aqueous solution) EH40: Not listed. IARC: Not listed. OSHA: Not considered a carcinogen under OSHA. ACGIH: Not listed Mutagenicity: No Reproductive Toxicity: No 12. ECOLOGICAL INFORMATION Ecotoxicological Information: Lithium bromide: 48 hr. EC50 = 364 mg/L (daphnia magna) [FMC I97-2170] 96 hr. LC50 > 976 mg/L (menidia beryllina) [FMC I97-2171] 96 hr. LC50 = 438 mg/L (rainbow trout) [FMC I97-2172] 96 hr. LC50 > 995 mg/L (mysid shrimp) [FMC I97-2173] Chemical Fate Information: LiBr exists as the inorganic ions of lithium and bromide in aqueous solutions. LiBr is not biodegraded, bioaccumulated or photodegraded. 13. DISPOSAL CONSIDERATIONS DISPOSAL METHOD: Dispose of waste according to local and Federal laws and regulations. 14. TRANSPORT INFORMATION PROPER SHIPPING NAME: CLASSIFICATION: LABELS: UN NUMBER: PACKING GROUP: FLASH POINT: CUSTOM TARIFF NO: MARINE POLLUTANT: PIH: None None None None None Not applicable 2827.59.0000 No Not designated Poison Inhalation Hazard by US DOT. 15. REGULATORY INFORMATION Page 5 of 5 MSDS Ref. No: QS-MSD-135 Version: US/Canada Date Approved: 15 Jan., 2014 Revision No: 10 UNITED STATES SECTION 311 HAZARD CATEGORY (40 CFR 370): SECTION 313 REPORTABLE INGREDIENTS (40 CFR 372): SECTION 302 EXTREMELY HAZARDOUS SUBSTANCES (40 CFR 355): CERCLA HAZARDOUS SUBSTANCE (40 CFR 302.4): TSCA SEC 12B EXPORT NOTIFICATION: TSCA INVENTORY STATUS (40 CFR 710): CANADA WHMIS: Immediate (Acute) Health Hazard This product does not contain a toxic chemical subject to the reporting requirements of Section 313 of Emergency Planning and Community Right-To-Know Act of 1986. Not listed Not listed This product is not subject to TSCA 12 (b) Export Notification Requirements. Listed Product Identification No.: None Hazard Classification: Class D, Division 2B (Eye and skin irritant, skin sensitizer) Ingredient Disclosure List: Not listed 16. OTHER INFORMATION REVISION SUMMARY: Revision No: 10. Regular review completed. No changes needed NFPA RATING HEALTH: 1 FLAMMABILITY: 0 REACTIVITY: 0 SPECIAL: none This MSDS has been prepared to meet U. S. OSHA Hazard Communication Standard, 29 CFR 1910.1200 and Canada's Workplace Hazardous Materials Information System (WHMIS) requirements. type 1a Copyright 2014. FMC Corporation, Lithium Division. All Rights Reserved. FMC Lithium, the FMC Lithium logo and ADVAGuard® are trademarks of FMC Corporation.